64Cu-DOTA-alendronate

N/A

Report date: 2026/03/11 20:02:12

Base Information

Drug Name64Cu-DOTA-alendronate
Drug Alias Name64Cu-DOTA-alendronate (Beckman Research Institute/City of Hope)alendronate-DOTA-[64Cu]Copper 64-DOTA-alendronate64 Cu-DOTA-alendronate
ClassificationRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsCalcinosisBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity of Hope
China Registration ClassN/A

Develop Information

Active CompaniesCity of HopeNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsCalcinosisBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A